Could a parasite drug beat warts? new trial tests ivermectin
NCT ID NCT07396714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial will test whether a cream containing ivermectin (a drug used for parasites) can treat common skin warts. It will compare ivermectin alone, ivermectin combined with microneedling (tiny needles to help the cream absorb), and a standard salicylic acid treatment. The study plans to enroll 88 people aged 11 to 80 with non-genital warts and will check results every two weeks for up to 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- topical ivermectin 1%
- What this could lead to
- If it works, this could offer a new topical treatment option for common skin warts.
- What could go wrong
- This is a very early, small trial (88 people) with no results yet. The treatment may not work better than existing options, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WARTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blister beetle extract banish common warts? phase 3 trial investigates
- Rare disease drug shows promise in reducing infections
- Heat and hydrogen peroxide patch takes on stubborn warts
- New hope for stubborn warts: extended treatment shows promise
- Wart war: which treatment wins – acid, fungus extract, or both?
- New gel could zap away common warts in just weeks